10/06/2024  09:30:21 Var. +0.750 Volume Denaro16:02:52 Lettera16:02:52 Capitalizzazione di mercato Dividend Y. Rapporto P/E
102.450EUR +0.74% 1
Fatturato: 102.450
101.700Quantità in denaro: 300 102.100Quantità in lettera: 300 12.5 bill.EUR - -

Descrizione business

Revvity offers products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Dr. Prahlad Singh
Consiglio di amministrazione
Max Krakowiak, Yves Dubaquie, Alan Fletcher, Magali Four, Joel Goldberg, Madhuri Hegde, Yi-Ping Lin, Dan Tereau, Jayashree Thacker, Miriame Victor, Tajinder Vohra, Kevin Willoe, Arvind Sundar-Rajan
Consiglio di sorveglianza
Alexis P. Michas, Peter Barrett, Samuel R. Chapin, Dr. Sylvie Grégoire, Dr. Michelle McMurry-Heath, Dr. Prahlad Singh, Michel Vounatsos, Frank Witney, Pascale Witz
 

Dati aziendali

Name: Revvity
Indirizzo: 940 Winter Street,Waltham, Massachusetts 02451, USA
Telefono: +1-781-663-6900
Fax: -
E-mail: -
Internet: https://www.revvity.com
Industria: Healthcare
Settore: Healthcare Providers
Sub settore: Healthcare Providers
Fine dell'anno finanziario: 31/12
Flottante libero: 60.70%
Data dell'IPO: 13/12/1960

Rapporti con gli investitori

Name: Steve Willoughby
IR telefono: +1-781-663-5677
IR Fax: -
IR e-mail: ir@revvity.com